v3.26.1
Condensed Consolidated Statements of Cash Flows
$ in Thousands
6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Cash flows from operating activities:    
Net loss $ (126,966) $ (85,037)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,560 1,248
Amortization of right-of-use asset 354 198
Accretion of discounts on marketable securities (446) (2,023)
Share-based compensation expense 16,752 11,050
Loss on disposal of property and equipment 78 891
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (11,995) (5,303)
Accounts payable 2,609 (8,758)
Accrued expenses and other current liabilities (1,843) (7,902)
Deferred revenue (0) (6,941)
Operating lease liabilities (433) 121
Net cash used in operating activities (120,330) (102,456)
Cash flows from investing activities:    
Purchases of in-process research and development assets (9,014) (6,246)
Purchases of marketable securities (302,177) (123,266)
Purchases of property and equipment (5,178) (4,570)
Maturities of marketable securities 0 75,000
Net cash used in investing activities (316,369) (59,082)
Cash flows from financing activities:    
Proceeds from public offerings 0 172,500
Payment of offering costs (364) (10,755)
Proceeds from exercise of stock options 1,287 428
Net cash provided by financing activities 923 162,173
Net (decrease) increase in cash and cash equivalents and restricted cash (435,776) 635
Cash and cash equivalents and restricted cash at beginning of period 653,692 143,451
Cash and cash equivalents and restricted cash at end of period 217,916 144,086
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents 217,706 143,876
Restricted cash 210 210
Total cash, cash equivalents, and restricted cash 217,916 144,086
Supplemental disclosures of non-cash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 1,318 0
Purchases of in-process research and development assets, including payments owed upon achievement of development milestones, in accounts payable and accrued expenses 986 0
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities 189 1,287
Remeasurement of operating right-of-use asset and lease liability due to lease modification $ 0 $ 811